Impaired T-cell response to mRNA vaccination heralds risk of COVID-19 in long-term allogeneic hematopoietic stem cell transplantation survivors

Haematologica. 2024 Jan 1;109(1):303-307. doi: 10.3324/haematol.2023.283551.
No abstract available

MeSH terms

  • COVID-19* / prevention & control
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Humans
  • Survivors
  • T-Lymphocytes
  • Vaccination

Grants and funding

Funding: This work was supported by the Swedish Medical Research Council (Vetenskapsrådet; grant no. 2021-04779), and the Gothenburg Society of Medicine (GLS-961772).